- Home
- About
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Private Event – Metabolic Wellness Considerations In Schizophrenia
Private Event – Metabolic Wellness Considerations In Schizophrenia
A Private Event for Partners Health Management.
This presentation addresses the high prevalence of cardiometabolic risk factors in schizophrenia and the importance of maintaining wellness in patients. The discussion will review the cardiometabolic guidelines specific for patients with schizophrenia and explore coordinated wellness programs to best impact outcomes.
Featuring
-
Michelle Jacobs, PharmD, BCPS, BC-ADM, CDE, RPh (OPDC)
Former Senior Medical Science Liaison
-
Jason Swartz, RPh, MBA (OPDC)
Managed Market Liaison
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Joint Live Event – Major Depressive Disorder (MDD) in Chronic Kidney Disease (CKD)
July 12 6:30 pm to 8:30 pm -
Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder
July 13 6:00 pm to 9:00 pm
Register
This event registration is closed.
Stay Connected:
- Resource Library